HALOZYME THERAPEUTICS INC's ticker is and the CUSIP is 40637HAD1. A total of 47 filers reported holding HALOZYME THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $17,880,122 | -5.7% | 21,190,000 | -7.2% | 0.01% | +8.3% |
| Q2 2023 | $18,961,913 | +9.1% | 22,830,000 | +11.4% | 0.01% | 0.0% |
| Q1 2023 | $17,373,955 | -11.0% | 20,500,000 | +1.7% | 0.01% | -25.0% |
| Q4 2022 | $19,522,341 | +12.4% | 20,165,000 | -1.7% | 0.02% | +33.3% |
| Q3 2022 | $17,362,000 | -6.6% | 20,516,000 | -2.7% | 0.01% | -14.3% |
| Q2 2022 | $18,597,000 | +166.8% | 21,081,000 | +163.5% | 0.01% | +250.0% |
| Q1 2022 | $6,970,000 | – | 8,000,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wellesley Asset Management | 71,432 | $63,617,000 | 4.32% |
| Western Asset Management Company, LLC | 15,600,000 | $13,690,000 | 4.04% |
| CAMDEN ASSET MANAGEMENT L P /CA | 70,849,000 | $61,727,000 | 1.84% |
| ZAZOVE ASSOCIATES LLC | 16,992,000 | $14,985,000 | 1.32% |
| Penn Mutual Asset Management, LLC | 1,305,000 | $1,137,000 | 1.32% |
| DAVIDSON KEMPNER CAPITAL MANAGEMENT LP | 64,750,000 | $56,413,000 | 0.72% |
| CQS (US), LLC | 10,000,000 | $8,777,000 | 0.61% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 28,859,000 | $25,319,000 | 0.40% |
| Context Capital Management, LLC | 4,122 | $3,632,000 | 0.24% |
| Hudson Bay Capital Management LP | 19,500,000 | $17,152,000 | 0.23% |